Abstract:
Ethnopharmacological relevance: Bacterial infections remain a significant threat to
human health. Due to the emergence of widespread antibiotic resistance,
development of novel antibiotics is required in order to ensure that effective
treatment remains available. There are several reports on the ethnomedical use of
Tabernaemontana elegans pertaining to antibacterial activity.
Aim of the study: The aim of this study was to isolate and identify the fraction
responsible for the antimicrobial activity in T. elegans (Stapf.) root extracts.
Materials and methods: The active fraction was characterised by thin layer
chromatography (TLC) and gas chromatography – mass spectrometry (GC-MS).
Antibacterial activity was determined using the broth micro-dilution assay and
antimycobacterial activity using the BACTEC radiometric assay. Cytotoxicity of the
crude extract and fractions was assessed against primary cell cultures; lymphocytes
and fibroblasts; as well as a hepatocarcinoma (HepG2) and macrophage (THP-1)
cell line using the Neutral Red uptake and MTT assays.
Results: The crude root extracts were found to contain a high concentration of
alkaloids (1.2% w/w). GC-MS analysis identified the indole alkaloids, voacangine and
dregamine, as major components. Antibacterial activity was limited to the Grampositive
bacteria and Mycobacterium species, with MIC values in the range of 64 –
256 μg/ml. When combined with antibiotics, additive antibacterial effects were
observed. Marked cytotoxicity to all cell lines tested was evident in the MTT and
Neutral Red uptake assays, with IC50 values < 9.81 μg/ml.Conclusions: This study confirms the antibacterial activity of T. elegans and supports
its potential for being investigated further for the development of a novel antibacterial
compound.
